Fiona Marshall discovered a love for science at school. She eschewed medicine for biochemistry at the University of Bath and then chose neuroscience for her PhD at Cambridge, while also accumulating industry experience. She lived through the transformation of Glaxo to GSK, shifted to biotech at Millennium where she worked with the likes of Allan Marchington …
“The vision at NICE is to be at the forefront of delivering access for patients in the NHS to valuable, evidence-based innovative medicines, medical devices and diagnostics. The changes that we are making will provide a robust foundation for our evaluations now and in the future and enable us to continue to lead the way …
NICE: Greater flexibility & fairer patient access Read More »
At the age of 10 she wanted to be a vet, at 17 a scientist, and at 21 she settled on medicine. Gillian Leng trained as a doctor at Leeds University, studied peripheral arterial disease in Edinburgh for several years, then worked as a consultant in public health in Bedfordshire. It’s no surprise that she …
Born into a medical family on the Isle of Skye, Dr Calum Macrae’s path to Edinburgh University and London to study medicine and become a leading cardiologist, geneticist and developmental biologist is not a great surprise. His drive to “follow the science” took him to Boston where he trained with seminal thought leaders in human genetics and …
The conversation between Nigel Gaymond (in London amid rain of biblical proportions) and Mike Grey (in Utah amid smoke-filled air brought about by severe drought and forest fires) brought into sharp relief the weather extremes our planet is experiencing. Brought up in the West Midlands, Mike studied Chemistry at Nottingham University with support from local …
Dr Annalisa Jenkins grew up in the south of England in a naval family. Having discovered a passion medicine at an early age, she received offers from several medical schools and chose St. Bart’s – because it was in London (much to her parents’ chagrin). While in med school, she gained essential financial support for …
Justin Gover is the ex-CEO of GW Pharma—a great UK success story—known for treatments for epilepsy and the multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Justin shares his journey from studying politics at Bristol University to honing his skills at the global …
John Young, Chief Business Officer at Pfizer, is that increasing rarity in today’s world, a one-company man who has never even interviewed elsewhere. John shares his journey from being raised in rural Dumfriesshire, Scotland, and schooled in Lockerbie, to studying biological sciences at Glasgow University, doing postgrad work at Strathclyde University, to deciding the lab …
Mark Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific, grew up in the West Country in Gloucestershire (though he sheepishly admits to having lost his burr). He attended Reading University, attracted by their programme of industrial placements. Mark shares his journey from studying science and business to a training program at Perkin Elmer …
Dr Rupert Vessey—President of Early Development and Research at Bristol Myers Squibb—shares his journey from following the family tradition into medicine with Sir John Bell at Oxford University as his advisor while juggling a love and talent for rugby to then honing in on a career in research that led to his leadership role in …
Dr David Pyott—portfolio board member, philanthropist, and former CEO & Chairman of Allergan—was destined for an international life which led to him live in 10 countries and work in 7. He shares his journey, from growing up in India and becoming fluent in Marathi, to attending Edinburgh University and London Business School, to becoming CEO …
Dr Clive Meanwell—founder & CEO of Population Health Partners; founder & former CEO of The Medicines Company—shares his journey emanating from a family of teachers in Birmingham to earning his medical degree at University of Birmingham and playing first class rugby to a corporate career that led to him founding and leading The Medicines Company …
Nigel Gaymond, BELS Founder & Executive Chairman, provides a brief overview of BELS (British Educated Life Scientists) & the BELS Brief Chats podcast.
We’re delighted to welcome Dr Rupert Vessey to the BELS Advisory Council. Based in the US as EVP and President of Research & Early Discovery for Bristol Myers Squibb, his work includes several initiatives in the UK. His perspectives on the sector in the UK and globally will be invaluable as we expand the work …
Thankfully, COVID lockdown restrictions are now easing. The number of daily COVID-19 vaccine doses administered in the UK recently hit record highs. Over half of the adult population has now received at least one dose of a vaccine, and 2,228,772 people have been fully vaccinated. While the UK health and life sciences sector has made …
